China Traditional Chinese Medicine Holdings Co. Limited
CHIZF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $16,510 | $18,122 | $14,304 | $19,053 |
| % Growth | -8.9% | 26.7% | -24.9% | – |
| Cost of Goods Sold | $8,653 | $8,847 | $7,106 | $7,224 |
| Gross Profit | $7,856 | $9,274 | $7,198 | $11,829 |
| % Margin | 47.6% | 51.2% | 50.3% | 62.1% |
| R&D Expenses | $596 | $686 | $612 | $694 |
| G&A Expenses | $1,058 | $1,043 | $944 | $974 |
| SG&A Expenses | $6,477 | $7,447 | $5,549 | $8,556 |
| Sales & Mktg Exp. | $5,419 | $6,403 | $4,604 | $7,582 |
| Other Operating Expenses | $448 | -$285 | -$26 | -$128 |
| Operating Expenses | $7,521 | $7,847 | $6,134 | $9,123 |
| Operating Income | $336 | $1,427 | $1,064 | $2,753 |
| % Margin | 2% | 7.9% | 7.4% | 14.4% |
| Other Income/Exp. Net | -$172 | -$203 | -$224 | -$233 |
| Pre-Tax Income | $163 | $1,225 | $840 | $2,520 |
| Tax Expense | $142 | -$172 | $119 | $397 |
| Net Income | $54 | $1,285 | $764 | $1,933 |
| % Margin | 0.3% | 7.1% | 5.3% | 10.1% |
| EPS | 0.011 | 0.26 | 0.15 | 0.38 |
| % Growth | -95.9% | 73.3% | -60.5% | – |
| EPS Diluted | 0.011 | 0.26 | 0.15 | 0.38 |
| Weighted Avg Shares Out | 5,036 | 5,036 | 5,036 | 5,036 |
| Weighted Avg Shares Out Dil | 5,036 | 5,036 | 5,036 | 5,036 |
| Supplemental Information | – | – | – | – |
| Interest Income | $48 | $65 | $67 | $63 |
| Interest Expense | $236 | $199 | $221 | $222 |
| Depreciation & Amortization | $1,130 | $1,133 | $1,099 | $850 |
| EBITDA | $1,529 | $2,557 | $2,160 | $3,592 |
| % Margin | 9.3% | 14.1% | 15.1% | 18.9% |